- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Genetic risk scores may help identify diabetes patients at high risk of developing DKD
Australia: Findings from a systematic review published in the Journal of Clinical Endocrinology & Metabolism support the efficacy of genetic risk scores (GRSs) in identifying people with diabetes at a high risk of developing diabetic kidney disease (DKD).
"The research reveals that there is moderate evidence to support the utility of genetic risk scores to identify diabetic patients who are at high risk of developing DKD." the researchers wrote. "In practice, a robust GRS could be used at the first clinical encounter with a person with diabetes to stratify their risk of complications."
A third of people with diabetes can develop diabetic kidney disease, which is the leading cause of end-stage renal disease. Measures to treat and prevent require better identification of patients most at risk.
Genome-wide association studies (GWAS) have found genetic variants associated with DKD risk, but it is difficult to translate findings into clinical benefit because individual variants explain a relatively small proportion of overall risk. However, a genetic risk score aggregates the individual effects of variants to increase their predictive power.
In the systematic review, Aleena Shujaat Ali, The University of Melbourne, Melbourne, Australia, and colleagues summarized the existing evidence of genetic risk scores and their utility for predicting DKD in patients with type 1 or type 2 diabetes.
For this purpose, the researchers searched the online databases in June 2022 to identify all relevant and existing literature. The main data items that were sought included sample size, study design, single nucleotide polymorphisms of interest, population, DKD-related outcomes, and relevant summary measures of result. The methodological quality of studies was evaluated using the Critical Appraisal Skills Programme checklist.
The researchers identified 400 citations, of which fifteen were included in the review. Overall, seven studies had positive results, 5 had mixed results, and negative results were seen in 3. Most studies with the strongest methodological quality (n = 9) reported favourable and statistically significant findings of a GRS’s association with at least one measure of DKD.
According to the authors, the systematic review is the first to support the GRS's utility to identify diabetes patients at high risk of DKD development. They added, "In practice, a robust GRS could be used at the finest clinical encounter for a diabetic person."
A report could be generated from a routine blood test, allowing the clinicians a targeted approach to the frequency of surveillance and diabetes medication selection. This would be particularly useful and allow high-risk people to be prioritized for review earlier in the course of the disease if done at the time of diagnosis.
"Renoprotective agents could then be used with close specialist surveillance to reduce DKD progression. This could ultimately delay or prevent the development of DKD," the researchers concluded.
Reference:
Ali, A. S., Pham, C., Morahan, G., & Ekinci, E. I. Genetic Risk Scores Identify People at High Risk of Developing Diabetic Kidney Disease: A Systematic Review. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad704
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751